Theralase(R) Releases 2Q2025 Financial Statements #Chemicals #Pharmaceutical #Biotechnology #HealthCare #Medical #Pharmaceuticals #Technology #QuarterlyResults #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Investing

Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses has released the Company's unaudited condensed consolidated interim 2Q2025 financial statements ("Financial Statements").Theralase® will be hosting a conference call on Wednesday, September 3rd at 11:00 am...


http://dlvr.it/TMjLsK

Comments

Popular posts from this blog

SEC Investor Advisory Committee to Discuss Exempt Offerings and Accredited Investors at September 21 Meeting #Banking #FinancialServices

Cleantek Industries Inc. Announces a Twelve-Month Extension of Credit Facility #CTEK.CA #CTEK.V #GLKFF #Investing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Technology

Hearts Connect along the Silk Road, International Voluntary Service Seminar Held in Nanjing #